FDA opens investigation into new outbreak

The Food and Drug Administration is investigating a new outbreak of Salmonella Newport infections.

The source of the outbreak has not been determined. The FDA reports that there are seven confirmed patients in the outbreak. However, the agency is not reporting their ages or where they live.

The FDA has not begun any traceback efforts yet. Similarly, the agency has not begun any site inspections or sample testing.

In other outbreak news, the FDA continues to investigate two outbreaks. Those outbreaks are:

An outbreak of infant botulism traced to ByHeart powdered infant formula – As of the most recent update on Jan. 23, there are 51 confirmed patients across 19 states. All of the patients have required hospitalization but none have died. An outbreak of Listeria monocytogenes infections traced to pasta meals – As of the most recent update on Oct. 30, 2025, there were 27 patients across 18 states. Of the patients with information available, 25 have required hospitalization and six have died.

In additional outbreak news, the FDA has released an Executive Summary of Salmonella Richmond illnesses traced to moringa leaf powder. The outbreak has sickened 65 people across 28 states. Fourteen of the patients have required hospitalization, but none have died. The first patient became ill on May 12, 2025 and the most recent patient became ill on Jan. 11 this year.

The summary was partially redacted, with some of the names of stores where the implicated product was sold blacked out. The report did name Member’s Mark brand and Sam’s Club as having been linked to the outbreak. The FDA did not discover how the moringa leaf powder became contaminated.